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Background: The lymphotoxin-α (LT-α) gene is located on chromosome 6 (6p21.1-
6p21.3) and it may regulate tumor necrosis factor (TNF) production. TNF is a potent 
cytokine in the airway inflammatory response. Polymorphisms of TNF-associated 
genes have been related to asthma. This study investigated an LT-α-NcoI polymorphism 
in the first intron of the LT-α gene (LT-α-NcoI*1 allele, as a variant type; and LT-α-NcoI*2 
allele), which may predispose individuals to asthma and atopy.
Methods: Polymerase chain reaction-based assays were performed to determine 
LT-α-NcoI genotypes among our subjects. A genetic case control analysis was then 
performed on 114 atopic asthmatic and 155 non-asthmatic unrelated children.
Results: There was a statistically higher frequency of LT-α-NcoI*1 allele carriers 
(1/1 + 1/2) in the subjects with atopic asthma than in controls (OR = 1.923; 95% 
CI = 1.061−3.484; p = 0.031).
Conclusion: The results indicate that LT-α-NcoI*1 may be a risk factor for atopic 
asthma in Taiwanese children.
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1. Introduction
Asthma is an airway inflammatory disease charac-
terized by reversible airway obstruction and in-
creased airway responsiveness.1,2 The etiology of 
the disease is multifactorial, with environmental and 
genetic components. Genetic components have 
been mentioned by segregation analysis.3−5 More 
than 90% of children with asthma are associated 
with atopy, which involves increased total serum IgE, 
specific IgE response to allergens or skin prick test 
reactivity or both.6,7 Also, patients with asthma and 
atopy have higher peripheral serum eosinophil 
counts, and eosinophils are increased in the lung tis-
sue and bronchoalveolar fluid of asthmatics.8 Mature 
eosinophils are important effectors of allergic in-
flammation, releasing proinflammatory proteins 
from their granules such as major basic protein, 
peroxidase and cationic protein.9
The airway inflammatory response of asthma is 
now known to be associated with the release of 
multiple inflammatory mediators and cytokines. 
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Tumor necrosis factor (TNF) is a powerful proin-
flammatory cytokine that participates in the airway 
inflammatory response in patients with atopic asth-
ma.10 The lymphotoxin-α (LT-α) gene (or TNF-β 
gene), which encodes TNF-β production, is located 
within the class III human major histocompatibility 
complex (MHC) on chromosome 6 (6p21.1-6p21.3).11 
A previous study suggested an important functional 
role for genes on 6p21.1 in the pathogenesis of at-
opic asthma.12 Also, the level of TNF secretion seems 
to be associated with allele 1 of a NcoI polymor-
phism in the first intron of the LT-α gene (or TNF-β 
gene).13 In addition, the LT-α gene may regulate TNF 
gene expression.14 Studies have shown that a number 
of cytokine gene single-nucleotide polymorphisms 
(SNP) may affect their transcription and influence 
the level of cytokine production.15,16 Thus, the LT-α 
gene is considered a candidate gene for association 
with asthma.17,18
The present study was performed to determine 
the prevalence of the LT-α NcoI genotype in atopic 
asthmatic and healthy children in Taiwan, and to 
determine whether the variants contribute to the 
risk of atopic asthma.
2. Methods
A total of 269 independent subjects were collected 
from two populations in the Taichung area for this 
study. The first population comprised 114 children 
with atopic asthma recruited from the Department 
of Pediatrics, Chung Shan Medical University Hospital. 
The community controls comprised 155 non-
asthmatic students selected from three elementary 
schools in Taichung. The case and control groups 
were aged from 7 to 14 years.
Whole blood samples and questionnaires were 
collected when subjects were enrolled. Blood sam-
ples were obtained by venipuncture. Serum eosi-
nophil counts, serum total IgE and specific IgE levels 
were examined for each subject. Specific IgE was 
detected using the Cap system (Pharmacia, Uppsala, 
Sweden). Questionnaires included demographics, 
lifestyles, and medical histories. Atopy, as defined in 
our study, was diagnosed as total IgE concentrations 
greater than 200 IU/mL and a positive specific IgE 
titer against one or more of Bomia tropicalis, 
Dermatophagoides microrcers, Dermatophagoides 
pteronyssinus, Blatella germanica, cat dander, dog 
dander, Aspergillus fumigatus, Candida albicans, 
and Penicillin notatum.
2.1. Mutation analysis
Genomic DNA was extracted from the peripheral 
blood of study participants using the standard 
method. Polymerase chain reaction (PCR) of the LT-
α-NcoI polymorphisms was carried out using the LT-
α-NcoI primers 5-CCGTGCTT CGTGCTTTGGA CTA-3 
and 5-AGAGCTGGTGGGGA CATGTCTG-3. Genomic 
DNA, 100 ng, extracted from venous blood was added 
to a 20-µL reaction mixture containing 10 pmol of 
each primer with 2 mM of each dNTP (Gibco-BRL, 
USA), 10 mM Tris-HCl (pH 8.8), 1.5 mM MgCL2, 50 mM 
KCL, 0.1% Triton X-100 and 10 units of Taq DNA po-
lymerase (DyNAzyme II, Finland). Amplification con-
ditions were 95°C for 5 minutes followed by 35 cycles 
of 95°C for 30 seconds, 66°C for 1 minute, and 72°C 
for 1 minute. Following amplification, 8 µL of PCR 
prod ucts were digested with 1 µL of NcoI endonucle-
ase at 37°C for 16 hours. The resultant products were 
analyzed on 2% agarose gel with ethidium bromide.
The NcoI fragments of the LT-α-containing allele 
1 were identified by 195 bp and 545 bp fragments 
(LT-α-NcoI*1) as a variant type, and allele 2 by a 
single 740 bp band (LT-α-NcoI*2).13 Figure 1 shows 
the results of electrophoresis.
2.2. Statistical analysis
All statistical analyses were performed with SPSS 
statistical software (SPSS Inc., Chicago, IL, USA). 
Pearson’s χ2 test was applied to analyze the geno-
typic difference in frequency and male/female ratio 
between the two groups. Comparisons of age, serum 
total IgE, and serum eosinophil count between the 
atopic asthma and control groups were analyzed with 
Student’s t test; 95% confidence intervals were 
adopted and p < 0.05 were taken to indicate statis-
tically significant difference.
3. Results
In this study, there were more boys in the atopic 
asth ma group, but there was no statistically signifi-
cant difference in the male/female ratio between 
Figure 1  Results of electrophoresis of nine cases. Lanes 
1 and 2 (allele 2/allele 2) manifested a single 740 bp band; 
lanes 3−6 (allele 1/allele 2) manifested 195 bp, 545 bp 
and 740 bp bands; lanes 7−9 (allele 1/allele 1) manifested 
195 bp and 545 bp bands.
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the two groups (p = 0.56). The mean age of all sub-
jects was 9.55 ± 1.83 years (range, 7−14 years). The 
age of the children in the atopic asthma group 
seemed to be slightly higher than those of the con-
trol group (p = 0.02). There were significant differ-
ences in serum total IgE and eosinophil counts 
between the atopic asthma and control groups 
(p < 0.01) (Table 1).
Table 2 shows the genotypic frequencies of the 
LT-α-NcoI polymorphism in atopic asthmatic children 
and controls. The genotypic distributions were sig-
nificantly different between the two groups 
(p = 0.025). Table 3 shows the proportions of poly-
morphic LT-α-NcoI*1 carriers in the atopic asthma 
and control groups. LT-α-NcoI*1 carriers (homozygous 
and heterozygous) were present at a statistically 
higher frequency in the atopic asthma group than in 
the control group (OR = 1.923; 95% CI = 1.061−3.484, 
p = 0.031).
4. Discussion
The LT-α gene, which encodes TNF-β secretion, is 
located within the class III region of human major 
histocompatibility complex.11 In our study, we exam-
ined an LT-α-NcoI polymorphism of the LT-α gene. 
The polymorphic NcoI site is linked with an amino 
acid substitution of TNF-β protein at position 26, 
where the LT-α-NcoI*1 allele reveals asparagine and 
the LT-α-NcoI*2 allele reveals threonine.13
LT-α (TNF-β) is mainly produced by activated 
lymphocytes.19 It has been identified in two molec-
ular forms: a secreted form consisting of an LTα3 
homotrimer that binds to TNF receptors and a 
membrane-associated heterotrimeric form with 
LTαβ2 that binds to the LT-β receptor. The major 
effect of lymphotoxin is its cytotoxicity against sen-
sitive target cells. It shares many of the biological 
activities of TNF-α and has roles in lymphocyte 
homing.20 B cell proliferation and IgE synthesis also 
need the participation of LT-α.21,22 In addition, LT-α 
is known to be involved in the pathogenesis of vari-
ous diseases, including bacteria and malaria 
infection.23,24 Polymorphisms in the LT-α gene and 
the gene encoding its interacting protein, galectin-2, 
have been shown to be associated with myocardial 
infarction.25,26
In our study, the frequency of LT-α-NcoI*1 carriers 
was statistically higher in atopic asthmatic children 
than in controls, although the data showed only bor-
derline significance (OR = 1.923; 95% CI = 1.061−3.484; 
p = 0.031). There are several related studies in which 
carriers with LT-α-NcoI*1 were at a higher risk to 
develop asthma. In a Busselton study (Australia), 
asthma was significantly more common in carriers 
Table 1  Male ratio, age, serum IgE and eosinophil count in atopic asthma and control groups
 Male ratio Mean age (± SD) Mean serum IgE (± SD) Mean eosinophil count (± SD)
Atopic asthma 52.6% (60/114) 9.9 ± 4.1 yr 895 ± 420 IU/mL 521 ± 310 cells/mm3
Control 49.0% (76/155) 9.2 ± 2.53 yr 82 ± 55 IU/mL 173 ± 92 cells/mm3
p 0.56 0.02* < 0.01* < 0.01*
*Comparison of age, serum IgE and eosinophil count between atopic asthma and control groups was analyzed using Student’s t test.
Table 2  Genotypes of LT-α-NcoI polymorphism in control and atopic asthmatic children
 
Wild type (2/2)
 Heterozygous Homozygous 
  carrier type (1/2) carrier type (1/1) p χ
2
Atopic asthma 20 (17.5%) 69 (60.5%) 25 (22%) 0.025* 7.417
Control 45 (29%) 69 (44.5%) 41 (26.5%)
*Pearson’s χ2 test was applied to analyze the genotypic difference in frequency between the two groups.
Table 3  Proportions of LT-α-NcoI*1 carriers in control and atopic asthmatic children
 Wild type (2/2) Variant type (1/1 + 1/2) p OR (95% CI)
Atopic asthma 20 (17.5%) 94 (82.5%) 0.031* 1.923 (1.061−3.484)
Control 45 (29%) 110 (71%)
*Pearson’s χ2 test was applied to analyze the difference in LT-α-NcoI*1 carriers between the two groups.
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with LT-α-NcoI*1.27 Almost all of the asthmatics in 
that study were atopic. The results of the Busselton 
study resembled ours. But the Busselton study em-
ployed a simple definition of asthma based on a 
standard questionnaire. Answers to the question, 
“Have you had an attack of asthma on more than 
one occasion?” depended greatly on the previous 
medical care and education of individuals. In our 
study, the diagnosis of asthma was made by pediatric 
immunologists using the Global Initiative for Asthma 
(GINA) guidelines. Additionally, the severity of 
asthma in asthmatics was mild persisted or moder-
ate persisted. Our diagnosis of asthma was more 
precise than that in the Busselton study. Moreover, 
asthma may have its onset at any age, but 90% of 
asthmatic children have their first symptoms before 
the age of 5 years. In our study, the case and control 
groups were aged from 7 to 14 years. Thus, we might 
have little chance to have ongoing asthma in our 
control group.
In another Taiwanese study (in Kaohsiung), LT-α-
NcoI polymorphism was not associated with asthma 
alone.28 That result is not consistent with our data. 
The asthmatic children in our study were all atopic, 
but the subjects in the Kaohsiung study included 
both atopic and non-atopic asthmatic patients. The 
pathogenesis and modes of inheritance of atopic 
and non-atopic asthma are different. The chronic al-
lergic inflammation of the airway and rapid secre-
tion of the inflammatory airway are found in atopic 
asthma but not in non-atopic asthma.29 Interestingly, 
in the Kaohsiung study, when the atopic patients 
were selected from the asthmatic group, there was 
a significant association between the TNF-α-308*2/
LT-α-NcoI*1 haplotype and atopic asthma. It seems 
that the effects of the LT-α-NcoI gene polymorphism 
play a more important role in atopic individuals 
than in non-atopic individuals. Also, an Italian study 
indicated that LT-α-NcoI polymorphism was associ-
ated with atopy.30
Studies of cytokine gene polymorphisms, espe-
cially SNP, need a larger population to obtain a con-
vincing outcome. Besides, studies of SNP in different 
areas, even in the same race, are also referable.12,27 
Although there were similar studies about the asso-
ciation between LT-α-NcoI polymorphism and asthma 
in Tainan and Kaohsiung,28,31 our samples were 
mainly recruited from the Taichung area. In this way, 
our data might increase the credibility of the asso-
ciation between LT-α-NcoI polymorphism and atopic 
asthma in the Taiwanese population.
LT-α-NcoI*1 allele leads to a higher TNF-β re-
sponse.13 It is conceivable that an allelically varying 
TNF-β response of activated T lymphocytes might 
contribute to the slow and self-protruding inflamma-
tory mechanisms of local immunological reactions. 
As we know, TNF-β is categorized as a Th1 cytokine. 
In contrast to the data that Th2-mediated inflamma-
tion is dominant in allergen-induced asthma, several 
papers have shown, surprisingly, that the addition 
of allergen-specific Th1 cells and cytokines could 
exacerbate airway inflammation.32,33 From our re-
sults, the total frequency of the LT-α-NcoI*1 allele 
in the atopic asthma group (52.2%) was not statis-
tically higher than that in the control group (48.7%; 
p = 0.434, data not shown). But probably due to the 
increment of heterozygous carriers (allele1/allele2), 
our results still showed that the frequency of whole 
LT-α-NcoI*1 carriers (allele1/allele2; allele1/allele1) 
was statistically higher in subjects with atopic 
asthma than in controls. Our results may be due to 
the interactions between LT-α-NcoI*1 carriers and 
TNF-β production. It is possible that increasing fre-
quency of LT-α-NcoI*1 carriers, whether homozygous 
or heterozygous carriers, resulted in a higher TNF-β 
response, which might disturb the Th1/Th2 balance 
and exacerbate the airway inflammatory reactions 
of atopic asthmatic children. Besides, some articles 
indicated that intron 1 of the LT-α gene, where the 
NcoI polymorphism is found, contains regulatory 
elements that affect TNF-α gene expression.12,14 
TNF-α has been previously shown to be involved in 
the pathogenesis of atopic asthma.34,35
Several negative studies were also reported.36,37 
In a Japanese study, no association was found be-
tween the LT-α-NcoI polymorphism and asthma, but 
another functional polymorphism, LT-α-753G/A, was 
found for the development of clinical asthma.37,38 
It was concluded that polymorphisms of the TNF 
gene family on chromosome 6p21.1, including TNF-α, 
LT-α and LT-β genes, play an important role in the 
pathogenesis of atopic asthma. Also, the authors 
stated that the minor contribution of the LT-α-NcoI 
polymorphism in the first intron of the LT-α gene 
to asthma susceptibility could not be excluded.
Asthma is a polygenetic disorder in which several 
candidate genes are involved. Each candidate gene 
may modify airway inflammation but each one may 
have only a puny effect. Although our sample size (a 
total of 269 independent cases) was similar (even 
slightly larger) to those associated studies in Taiwan, 
more study is required to corroborate our results.
In conclusion, we did find a statistical association 
between atopic asthma and LT-α-NcoI*1 carriers in 
Taiwanese children, even though LT-α-NcoI polymor-
phism may have only a minor effect on atopic 
asthma.
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